Next New Releases from NCBI BookshelfSpesolimab (Spevigo): Indication: For the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients 12 years of age and older and weighing at least 40 kg: Reimbursement Recommendation [Internet].Spesolimab (Spevigo): Indication: For the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients 12 years of age and older and weighing at least 40 kg: Reimbursement Recommendation [Internet].
